The study determined that p53 signatures and serous tubal intraepithelial carcinomas are precursors of ovarian carcinoma; they were detectable in fallopian tubes but full malignant behaviour of oncogenic variations (including of BRCA) was not evident until the cells had migrated to another environment in the ovary and surrounding tissues. The gene discussed is TP53; the disease is ovarian carcinoma.